Directory
>
Ouzama Henry
Ouzama Henry
Vice President Clinical Development | Dynavax Technologies
Raleigh, North Carolina, United States
Ouzama Henry
Summary
Ouzama Henry is a seasoned clinical development executive with over two decades of experience in the pharmaceutical industry. Currently serving as Vice President of Clinical Development at Dynavax Technologies, he is dedicated to advancing human health through innovative clinical research and drug development. Ouzama has a strong background in leading cross-functional teams, fostering collaboration, and driving transformational leadership within organizations. His academic credentials include a Doctor of Medicine from Harvard Medical School and a Master's in Epidemiology from Columbia University. Ouzama's career has spanned significant roles at GSK and Merck, where he has demonstrated a commitment to developing vaccines and therapies that can significantly impact public health. He is passionate about cultivating a diverse professional community and is known for his creativity and insight in clinical strategy.
Ouzama Henry
Work Experience
Vice President Clinical Development at
Dynavax Technologies
June 2022 - Present
Vice President and Head, Clinical R&D, GSK Vaccines, Rockville, MD at
GSK
July 2020 - June 2022
Senior Director, GSK Vaccines at
GSK
April 2012 - July 2020
Director, Clinical Development (Biologicals) at
GSK
October 2009 - April 2012
Associate Director at
Merck
August 2007 - October 2009
Ouzama Henry
Education
Harvard Medical School, Doctor Of Medicine - Md
January 1998
Columbia University Mailman School of Public Health, Masters In Science
Harvard University, Bachelor Of Arts - Ba
Frequently Asked Questions about Ouzama Henry
What is Ouzama Henry email address?
Ouzama Henry's primary email address is ******@dynavax.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Ouzama Henry work for?
Ouzama Henry is a Vice President Clinical Development at Dynavax Technologies, a company specializing in Commercial physical research.
Where Ouzama Henry graduated from?
Ouzama Henry holds a degree in from Harvard Medical School.
How can I directly contact Ouzama Henry?
To contact Ouzama Henry directly, you can use the email address ******@dynavax.com. Complete contact information is available upon registration with Muraena.
Who is Ouzama Henry?
Ouzama Henry is a seasoned clinical development executive with over two decades of experience in the pharmaceutical industry. Currently serving as Vice President of Clinical Development at Dynavax Technologies, he is dedicated to advancing human health through innovative clinical research and drug development. Ouzama has a strong background in leading cross-functional teams, fostering collaboration, and driving transformational leadership within organizations. His academic credentials include a Doctor of Medicine from Harvard Medical School and a Master's in Epidemiology from Columbia University. Ouzama's career has spanned significant roles at GSK and Merck, where he has demonstrated a commitment to developing vaccines and therapies that can significantly impact public health. He is passionate about cultivating a diverse professional community and is known for his creativity and insight in clinical strategy.
Ouzama`s contact details
******@dynavax.com
Colleagues
Chief Executive Officer
Senior Vice President
Chief Medical Officer, SVP Clinical Development, Regulatory and Medical Affairs
Executive Director, Clinical Operations
Executive Director, Technical Operations
Executive Director Human Resources
Executive Director, Drug Safety & Pharmacovigilance
Vice President, Quality
Chief Human Resources Officer
Board Member / Audit Committee